TELA Bio, Inc. (TELA) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
TELA Bio, Inc. (TELA) Earnings Overview
As of June 22, 2026, TELA Bio, Inc. (TELA) reported trailing twelve-month net income of -$40M, reflecting +37.6% year-over-year growth. The company earned $-0.70 per diluted share over the past four quarters, with a net profit margin of -48.4%.
Looking at the long-term picture, TELA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$21M in fiscal 2018.
TELA Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTNT ($2M net income, 3.7% margin), ATRC (-$5M net income, -2.1% margin), NVCR (-$173M net income, -20.8% margin), TELA has room to improve margins relative to the peer group. Compare TELA vs XTNT →
TELA Earnings vs Peers
Earnings metrics vs comparable public companies
TELA Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$39M | -2.6% | -$34M | $-0.83 | -48.4% | -42.0% |
| 2024 | -$38M | +18.9% | -$34M | $-1.33 | -54.6% | -49.2% |
| 2023 | -$47M | -5.3% | -$44M | $-2.04 | -79.8% | -75.4% |
| 2022 | -$44M | -33.1% | -$39M | $-2.73 | -106.9% | -94.2% |
| 2021 | -$33M | -15.6% | -$29M | $-2.30 | -112.9% | -100.0% |
| 2020 | -$29M | -28.4% | -$25M | $-2.23 | -158.1% | -138.8% |
| 2019 | -$22M | -6.3% | -$19M | $-2.26 | -145.2% | -124.1% |
| 2018 | -$21M | +1.1% | -$18M | $-3.25 | -254.9% | -214.9% |
| 2017 | -$21M | - | -$17M | $-3.29 | -502.6% | -398.7% |
Download Data
Export TELA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TELA — Frequently Asked Questions
Quick answers to the most common questions about buying TELA stock.
What is TELA earnings per share (EPS)?
TELA trailing twelve-month (TTM) diluted EPS is $-0.70, reflecting +37.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is TELA Bio, Inc.'s net income?
TELA Bio, Inc. (TELA) trailing twelve-month net income is $-40M as of 2025. Earnings grew +37.6% year-over-year.
Is TELA profitable?
TELA is not currently profitable on a TTM basis, reporting a net loss of $-40M. Net margin is -48.4%. Investors should monitor for a return to profitability.
What is TELA's earnings growth rate?
TELA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are TELA's profit margins?
TELA Bio, Inc. net profit margin is -48.4%, operating margin is -42.0%, and gross margin is +67.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -223.4%.
Is TELA growing earnings?
Yes, TELA earnings are accelerating — EPS growth of +37.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-40M. Earnings momentum is strengthening.
What was TELA's best earnings year?
TELA Bio, Inc.'s highest annual net income on record is $-21M, achieved in fiscal year 2018. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were TELA's earnings last quarter?
TELA's most recent reported quarter was Q1 2026. Net income was $-12M with diluted EPS of $-0.21. For a full breakdown of all quarters, see the quarterly earnings table on this page.